
Medicine and Health
In Silico Design of New Dual Inhibitors of SARS-CoV-2 M PRO through Ligand-and Structure-Based Methods
A. Bono, A. Lauria, et al.
Unlocking the secrets of SARS-CoV-2, this innovative study led by Alessia Bono, Antonino Lauria, Gabriele La Monica, Federica Alamia, Francesco Mingoia, and Annamaria Martorana reveals promising dual-binding site inhibitors. These compounds showcase potential against the viral main protease, a pivotal player in viral replication, proving to be a beacon of hope in drug discovery.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.